Thanks for the info. relating to PRLN, but volume is so thin your post will have no intended or unintended effect.
Mr. Schonsheck:
Thank you for your post and link conveying information about recent FTC guidelines. However any implication that this will have short-term positive effects on the PRLN stock price does not make sense (if this was your intention).
Volume on the stock was only 2,100 to 15,600 shares per day from 11/13 to date. At these levels, especially at 2100 to 3000 per day, the Market Makers are sitting in the catbird seat and not you.
However, in the short run, the BioFit Program might serve as a good marketing tool until it is overtaken by the big pharma companies that are already selling St. John's wort, Ginseng, and other products (for example under their vitamin labels such as the "Centrum" brand). And the latter companies are, as you should know, experts in the clinical, made to standard operating procedures and guaranteed potency, programs that Paracelsian is just now delving into. And many of the large pharmaceutical companies that are not marketing nutraceuticals right now, will be approaching the market shortly, or are now actively reviewing their competitive intelligence in this area.
Good luck.
Regards,
Jake Blackmerlin |
